These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

481 related items for PubMed ID: 18418318

  • 21. Malignant transformation in IgM monoclonal gammopathy of undetermined significance.
    Montoto S, Rozman M, Rosiñol L, Nadal E, Giné E, Aymerich M, Ferrer A, Esteve J, Bosch F, López-Guillermo A, Bladé J, Montserrat E.
    Semin Oncol; 2003 Apr; 30(2):178-81. PubMed ID: 12720132
    [Abstract] [Full Text] [Related]

  • 22. [Neurological manifestations of monoclonal gammopathies].
    Chassande B, Léger JM.
    Rev Prat; 1993 Feb 01; 43(3):314-6. PubMed ID: 8389055
    [Abstract] [Full Text] [Related]

  • 23. Pathogenesis and therapy of neuropathies associated with monoclonal gammopathies.
    Latov N.
    Ann Neurol; 1995 May 01; 37 Suppl 1():S32-42. PubMed ID: 8968215
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Paraproteinemic neuropathies.
    Rojas-García R, Gallardo E, Illa I.
    Presse Med; 2013 Jun 01; 42(6 Pt 2):e225-34. PubMed ID: 23618626
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Study of monoclonal gammopathy in Kagawa Prefectural Central Hospital].
    Uchida M, Taida N, Kanao M, Kagamihara H, Kuwajima M.
    Rinsho Byori; 2004 Jul 01; 52(7):574-9. PubMed ID: 15344556
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. AAEE case report #17: Peripheral neuropathy in monoclonal gammopathy of undetermined significance.
    Donofrio PD, Kelly JJ.
    Muscle Nerve; 1989 Jan 01; 12(1):1-8. PubMed ID: 2546074
    [Abstract] [Full Text] [Related]

  • 33. [Treatment of peripheral neuropathies associated with IgM anti-myelin monoclonal gammopathy].
    Mariette X, Oksenhendler E.
    Rev Neurol (Paris); 1996 May 01; 152(5):413-6. PubMed ID: 8881442
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Rituximab in the treatment of peripheral neuropathy associated with monoclonal gammopathy.
    Zivković SA.
    Expert Rev Neurother; 2006 Sep 01; 6(9):1267-74. PubMed ID: 17009914
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Antibodies to L-periaxin in sera of patients with peripheral neuropathy produce experimental sensory nerve conduction deficits.
    Lawlor MW, Richards MP, De Vries GH, Fisher MA, Stubbs EB.
    J Neurochem; 2002 Nov 01; 83(3):592-600. PubMed ID: 12390521
    [Abstract] [Full Text] [Related]

  • 38. Autoimmunity related to IgM monoclonal gammopathy of undetermined significance. Peripheral neuropathy and connective tissue sensibilization caused by IgM M-proteins.
    Jønsson V, Schrøder HD, Staehelin Jensen T, Nolsøe C, Stigsby B, Trojaborg W, Svejgaard A, Hippe E.
    Acta Med Scand; 1988 Nov 01; 223(3):255-61. PubMed ID: 3354352
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Plasma exchange in polyneuropathy associated with monoclonal gammopathy of undetermined significance.
    Dyck PJ, Low PA, Windebank AJ, Jaradeh SS, Gosselin S, Bourque P, Smith BE, Kratz KM, Karnes JL, Evans BA.
    N Engl J Med; 1991 Nov 21; 325(21):1482-6. PubMed ID: 1658648
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.